ENPP1 immunobiology as a therapeutic target

B Ruiz-Fernández de Córdoba, R Martínez-Monge… - Clinical Cancer …, 2023 - AACR
Abstract ENPP1 (ecto-nucleotide pyrophosphatase/phosphodiesterase) participates in the
hydrolysis of different purine nucleotides in an array of physiologic processes. However …

Neutrophil extracellular traps: New players in cancer research

J Zhao, J Jin - Frontiers in immunology, 2022 - frontiersin.org
NETs are chromatin-derived webs extruded from neutrophils as a result of either infection or
sterile stimulation using chemicals, cytokines, or microbes. In addition to the classical role …

ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer

S Wang, V Böhnert, AJ Joseph… - Proceedings of the …, 2023 - National Acad Sciences
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) expression correlates with
poor prognosis in many cancers, and we previously discovered that ENPP1 is the dominant …

[HTML][HTML] Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology

V Kumar, C Bauer, JH Stewart IV - European Journal of Cell Biology, 2023 - Elsevier
Pattern-recognition receptors (PRRs) are critical to recognizing endogenous and exogenous
threats to mount a protective proinflammatory innate immune response. PRRs may be …

[HTML][HTML] Human antibodies targeting ENPP1 as candidate therapeutics for cancers

X Chu, DS Baek, W Li, T Shyp, B Mooney… - Frontiers in …, 2023 - frontiersin.org
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane
glycoprotein expressed in many tissues. High expression levels of ENPP1 have been …

TET3 boosts hepatocyte autophagy and impairs non-alcoholic fatty liver disease by increasing ENPP1 promoter hypomethylation

F Sun, Y Yang, L Jia, QQ Dong, W Hu, H Tao… - Free Radical Biology …, 2024 - Elsevier
Background Dysregulated ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP)
family occurs in metabolic reprogramming pathological processes. Nonetheless, the …

Targeting neutrophil extracellular traps: A novel antitumor strategy

H Zuo, M Yang, Q Ji, S Fu, X Pu… - Journal of …, 2023 - Wiley Online Library
The clinical efficacy of surgery, radiotherapy, and chemotherapy for cancer is usually limited
by the deterioration of tumor microenvironment (TME). Neutrophil extracellular traps (NETs) …

[HTML][HTML] Advances in Melanoma: From Genetic Insights to Therapeutic Innovations

F Valdez-Salazar, LA Jiménez-Del Rio… - Biomedicines, 2024 - mdpi.com
Advances in melanoma research have unveiled critical insights into its genetic and
molecular landscape, leading to significant therapeutic innovations. This review explores the …

Neutrophil extracellular traps in tumor progression and immunotherapy

M Yan, Y Gu, H Sun, Q Ge - Frontiers in Immunology, 2023 - frontiersin.org
Tumor immunity is a growing field of research that involves immune cells within the tumor
microenvironment. Neutrophil extracellular traps (NETs) are neutrophil-derived extracellular …

Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression

X Ma, M Chen, L Meng - Acta Pharmacologica Sinica, 2024 - nature.com
Cytosolic double-stranded DNA (dsDNA) is frequently accumulated in cancer cells due to
chromosomal instability or exogenous stimulation. Cyclic GMP-AMP synthase (cGAS) acts …